ArticleAIDS research and therapy2024

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.

Sharon Walmsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.